Skip to main content
INVION LIMITED logo

INVION LIMITED — Investor Relations & Filings

Ticker · IVX ISIN · AU000000IVX4 LEI · 529900JY0HVEQEMSSJ32 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,119 across all filing types
Latest filing 2011-11-22 Investor Presentation
Country AU Australia
Listing ASX IVX

About INVION LIMITED

https://inviongroup.com

Invion Limited is a life sciences company dedicated to the development and commercialization of Photosoft technology, a next-generation Photodynamic Therapy (PDT). The company focuses on utilizing this light-activated treatment platform to target various forms of cancer and infectious diseases. Photosoft technology is derived from natural chlorophyll and is designed to selectively destroy malignant cells while minimizing damage to healthy tissue. Invion's research and development efforts are primarily directed toward oncology applications, including the treatment of skin, lung, and ovarian cancers, as well as addressing global health challenges through the treatment of viral and bacterial infections. The company aims to provide non-invasive or minimally invasive therapeutic alternatives that offer improved patient outcomes and reduced side effects compared to conventional treatment modalities.

Recent filings

Filing Released Lang Actions
CBio Clinical Trial Data presented at ACR Meeting 2 pages 256.7KB
Investor Presentation Classification · 95% confidence The document is a detailed presentation of clinical trial data for a pharmaceutical product (Cpn10) presented at a scientific meeting (American College of Rheumatology Annual Scientific Meeting). It includes trial design, inclusion/exclusion criteria, patient demographics, clinical measures, adverse events, pharmacokinetics, and conclusions. The document is not a financial report, earnings release, regulatory filing, or management announcement. It is a scientific/clinical data presentation aimed at shareholders and investors, focusing on clinical trial results and drug efficacy/safety. This fits best with an Investor Presentation (IP) as it provides detailed information for investors about the company's clinical progress and potential market impact. The document length (11,891 characters) and content support this classification rather than a brief announcement or regulatory filing.
2011-11-22 English
Correction to Investment Presentation 19 Sept 2011 1
Regulatory Filings Classification · 95% confidence The document is a short letter addressed to the ASX Company Announcements Office, dated 21 November 2011. It is titled 'CORRECTION TO INVESTMENT PRESENTATION DATED 19 SEPTEMBER 2011' and clarifies an error in a previously lodged investment presentation. The content is a correction notice rather than the presentation itself or a detailed financial report. The document length is only 1658 characters, indicating it is a brief announcement. According to the rules, such short documents that announce or correct presentations without containing substantive financial data or detailed report content should be classified as Regulatory Filings (RNS).
2011-11-20 English
Resignations from the Board of Directors 2 pages 37.0KB
Board/Management Information Classification · 100% confidence The document is a formal announcement addressed to the ASX Company Announcements Office regarding the resignations of two members from the Board of Directors of CBio Limited. It provides detailed biographical information about the departing directors and includes a statement of thanks from the Chairman. There is no financial data, no mention of a report or meeting results, and no indication of other types of filings such as earnings, mergers, or legal matters. The content clearly fits the category of announcements related to changes in the company's board of directors or senior management. Therefore, the appropriate classification is Board/Management Information (MANG). The document length is 4056 characters, which is consistent with a typical management change announcement rather than a full report or transcript.
2011-11-20 English
Replacement 2011 AGM meeting documents 11 pages 255.9KB
AGM Information Classification · 100% confidence The document is a replacement explanatory memorandum and notice for an Annual General Meeting (AGM) of CBio Limited. It includes details about the AGM date, venue, resolutions to be considered (including remuneration report adoption and director elections), proxy voting instructions, and other procedural information related to the AGM. The document explicitly states it is for the AGM scheduled for 29 November 2011 and contains AGM meeting materials such as the notice, explanatory statement, and proxy form. There is no actual financial report or detailed financial statements included, but rather materials to be presented and voted on at the AGM. This fits the definition of AGM Information (AGM-R), which covers presentations and materials shared during the AGM. The document length (15,000 characters) and content confirm it is not a brief announcement or a report publication announcement but the actual AGM meeting documents.
2011-11-10 English
Ceasing to be a substantial holder 9 pages 222.2KB
Regulatory Filings
2011-11-09 English
Initial Director`s Interest Notices x 5 10 pages 35.9KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3X Initial Director’s Interest Notice' and references ASX listing rule 3.19A.1 and section 205G of the Corporations Act. It details the securities interests of various directors upon their appointment, including shares held directly or indirectly, and notes the absence of contracts related to these interests. The content is focused on disclosures of personal shareholdings and interests of company directors, which aligns with insider trading or director dealing notifications. There is no financial performance data, no management discussion, no earnings information, or other report types. The document is a formal notification of directors' personal share transactions or holdings as required by regulatory bodies. Therefore, the correct classification is Director's Dealing (DIRS). The document length and detail support a high confidence in this classification.
2011-11-09 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.